(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-2.25% $ 4.34
Live Chart Being Loaded With Signals
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors...
Stats | |
---|---|
Dzisiejszy wolumen | 321 167 |
Średni wolumen | 707 477 |
Kapitalizacja rynkowa | 359.41M |
EPS | $0 ( 2024-03-13 ) |
Następna data zysków | ( $-0.560 ) 2024-06-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.480 |
ATR14 | $0.00900 (0.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-03 | Redmile Group, Llc | Sell | 59 986 | Cash-settled Swaps |
2024-02-01 | Redmile Group, Llc | Sell | 19 700 | Cash-settled Swaps |
2024-02-01 | Redmile Group, Llc | Buy | 205 483 | Cash-settled Swaps |
2024-01-31 | Redmile Group, Llc | Buy | 150 000 | Cash-settled Swaps |
2024-01-29 | Redmile Group, Llc | Buy | 150 000 | Cash-settled Swaps |
INSIDER POWER |
---|
-45.66 |
Last 79 transactions |
Buy: 1 817 492 | Sell: 5 217 316 |
Wolumen Korelacja
ADC Therapeutics SA Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
K | 0.945 |
NKX | 0.942 |
OGN | 0.941 |
JWN | 0.941 |
SPCE | 0.937 |
ZME | 0.936 |
BIG | 0.933 |
BBWI | 0.933 |
GSL | 0.933 |
USPH | 0.931 |
10 Najbardziej negatywne korelacje | |
---|---|
FLRT | -0.949 |
SLB | -0.944 |
CANE | -0.944 |
OII | -0.943 |
IEZ | -0.94 |
OIH | -0.937 |
WHD | -0.937 |
HAL | -0.935 |
AFT | -0.934 |
BKR | -0.933 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ADC Therapeutics SA Korelacja - Waluta/Towar
ADC Therapeutics SA Finanse
Annual | 2023 |
Przychody: | $69.56M |
Zysk brutto: | $67.03M (96.36 %) |
EPS: | $-2.94 |
FY | 2023 |
Przychody: | $69.56M |
Zysk brutto: | $67.03M (96.36 %) |
EPS: | $-2.94 |
FY | 2022 |
Przychody: | $209.91M |
Zysk brutto: | $205.33M (97.82 %) |
EPS: | $-1.990 |
FY | 2021 |
Przychody: | $33.92M |
Zysk brutto: | $32.52M (95.89 %) |
EPS: | $-3.52 |
Financial Reports:
No articles found.
ADC Therapeutics SA
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second-line transplant-ineligible patients; and Phase I clinical trial for treatment of relapsed or refractory non-hodgkin lymphoma (NHL). The company is also developing camidanlumab tesirine, an ADC that has completed Phase I clinical trial to treat relapsed or refractory NHL; in Phase II clinical trial in relapsed or refractory hodgkin lymphoma; and in Phase Ib clinical trial for selected advanced solid tumors. In addition, it develops ADCT-602, which is in Phase Ia clinical trial for treatment of acute lymphoblastic leukemia; ADCT-601 and ADCT-901 that are in Phase Ia clinical trial for treatment of various solid tumors; and preclinical product candidates, including ADCT-701 and ADCT-901 for the treatment of solid tumors. It has a collaboration and license agreement with Genmab A/S, Bergenbio AS, Synaffix B.V., Mitsubishi Tanabe Pharma Corporation, Overland Pharmaceuticals, and MedImmune Limited. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej